Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis

Clinical Rheumatology

Volumn 29, Issue 9, 2010, Pages 957-964

  Dimitroulas, Theodoros ^a   Giannakoulas, Georgios ^a   Papadopoulou, Klio ^a   Sfetsios, Tilemahos ^a   Karvounis, Haralambos ^a   Dimitroula, Hariklia ^a   Parcharidou, Despina ^a   Koliakos, Georgios ^b   Garyfallos, Alexandros ^c   Styliadis, Ioannis ^a   Settas, Loukas ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Aristotle University and Hippokration General Hospital   (Greece)

Author keywords

Left atrial volume; N terminal pro brain natriuretic peptide; Pulmonary hypertension; Systemic sclerosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; N(G),N(G) DIMETHYLARGININE;

ADULT; ARTICLE; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FUNCTION; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS;

AGED; ARGININE; BIOLOGICAL MARKERS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY ARTERY; SCLERODERMA, SYSTEMIC; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 77956188894     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1494-3     Document Type: Article

References (43)

1. C Fonseca D Abraham M Ponticos 2009 Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis Curr Vasc Pharmacol 71 34 39 10.2174/157016109787354105
2. R Hesselstrand A Scheja GQ Shen A Wiik A Akesson 2003 The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis Rheumatology 42 534 540 10.1093/rheumatology/keg170 1:CAS:528: DC%2BD3sXit12ls7Y%3D 12649400
3. E Hachulla P de Groote V Gressin J Sibilia E Diot P Carpentier L Mouthon PY Hatron P Jego Y Allanore KP Tiev C Agard A Cosnes D Cirstea J Constans D Farge JF Viallard JR Harle F Patat B Imbert A Kahan J Cabane P Clerson L Guillevin M Humbert Itinér AIR-Sclérodermie Study Group 2009 The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France Arthritis Rheum 60 1831 1839 10.1002/art.24525 19479881
4. T Dimitroulas G Giannakoulas H Karvounis G Koliakos T Sfetsios H Dimitroula L Settas 2008 N-terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension Clin Rheumatol 27 655 658 10.1007/s10067-007-0828-2 18204995
5. S Simeoni G Lippi A Puccetti M Montagnana E Tinazzi D Prati R Corrocher C Lunardi 2008 N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH Rheumatol Int 28 657 660 10.1007/s00296-007-0510-7 1:CAS:528: DC%2BD1cXkt1Olur8%3D 18092166
6. T Dimitroulas G Giannakoulas H Karvounis H Dimitroula L Settas 2009 N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment Rheumatol Int 29 347 348 10.1007/s00296-008-0667-8 18690444
7. P Coral-Alvarado G Quintana MF Garces LA Cepeda JE Caminos F Rondon A Iglesias-Gamarra JF Restrepo 2009 Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis Rheumatol Int 29 1017 1024 10.1007/s00296-008-0829-8 1:CAS:528:DC%2BD1MXmslyiu7g%3D 19116719
8. T Dimitroulas G Giannakoulas T Sfetsios H Karvounis H Dimitroula G Koliakos L Settas 2008 Asymmetrical dimethylarginine in systemic sclerosis related pulmonary arterial hypertension Rheumatology 47 1682 1685 10.1093/rheumatology/ken346 1:CAS:528:DC%2BD1cXht1Oisr%2FI 18753191
9. MH Williams CE Handler R Akram CJ Smith C Das J Smee D Nair CP Denton CM Black JG Coghlan 2006 Role of N-terminal brain natriuretic peptide (NT-proBNP) in scleroderma-associated pulmonary arterial hypertension Eur Heart J 27 1485 1494 10.1093/eurheartj/ehi891 1:CAS:528:DC%2BD28Xnt1Giu7o%3D 16682379
10. T Dimitroulas G Giannakoulas H Karvounis T Sfetsios G Koliakos G Parcharidis L Settas 2007 Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension Int J Cardiol 121 135 137 10.1016/j.ijcard.2006.08.070 17088004
11. Giannoni A, Tani C, Clerico A, Passino C, Tavoni A, d'Ascanio A, Bombardieri S, Emdin M (2009) When the heart is burning: amino-terminal pro-brain natriuretic peptide as an early marker of cardiac involvement in active autoimmune rheumatic disease. Int J Cardiol (in press)
12. T Dimitroulas G Giannakoulas C Papadopoulou H Karvounis H Dimitroula G Koliakos T Karamitsos D Parcharidou L Settas 2010 Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction J Rheumatol 37 993 999 10.3899/jrheum.090931 20194451
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee 1980 Preliminary criteria for the classification of the systemic sclerosis (scleroderma) Arthritis Rheum 23 581 590 10.1002/art.1780230510
14. A Dooley B Gao N Bradley DJ Abraham CM Black M Jacobs KR Bruckdorfer 2006 Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine Rheumatology 45 676 684 10.1093/rheumatology/kei276 1:CAS:528:DC%2BD28Xmt1Wku70%3D 16399843
15. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms 1989 Recommendations for quantitation of the left ventricle by two-dimensional echocardiography J Am Soc Echocardiogr 2 358 367
16. JF Ren MN Kotler NL DePace GS Mintz D Kimbiris P Kalman J Ross 1983 Two-dimensional echocardiographic determination of left atrial emptying volume: a noninvasive index in quantifying the degree of nonrheumatic mitral regurgitation J Am Coll Cardiol 2 729 736 10.1016/S0735-1097(83)80313-1 1:STN:280:DyaL3s3ptF2qtg%3D%3D 6886234
17. P Currie J Seward G Reeder 1985 Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients Circulation 71 1162 1169 1:STN:280:DyaL2M3gt1agsQ%3D%3D 3995710
18. S Ommen R Nishimura D Hurrell KW Klarich 2000 Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study Mayo Clin Proc 75 24 29 10.4065/75.1.24 1:STN:280:DC%2BD3c%2FpsVCnuw%3D%3D 10630753
19. D Mukerjee D St George C Knight J Davar AU Wells RM Du Bois CM Black JG Coghlan 2004 Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis Rheumatology 43 461 466 10.1093/rheumatology/keh067 1:STN:280:DC%2BD2c7jt1Witw%3D%3D 15024134
20. C Tei KS Dujardin DO Hodge KR Bailey MD McGoon AJ Tajik SB Seward 1996 Doppler echocardiographic index for assessment of global right ventricular function J Am Soc Echocardiogr 9 838 847 10.1016/S0894-7317(96)90476-9 1:STN:280:DyaK2s%2FpvVOksQ%3D%3D 8943444
21. JE Pope P Lee M Baron J Dunne D Smith PS Docherty A Bookman M Abu-Hakima 2005 Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis J Rheumatol 32 1273 1278 15996064
22. AB de Azevedo PD Sampaio-Barros RM Torres C Moreira 2005 Prevalence of pulmonary hypertension in systemic sclerosis Clin Exp Rheumatol 23 447 454 16095111
23. E Hachulla V Gressin L Guillevin P Carpentier E Diot J Sibilia A Kahan J Cabane C Francès D Launay L Mouthon Y Allanore KP Tiev P Clerson P de Groote M Humbert 2005 Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study Arthritis Rheum 52 3792 3800 10.1002/art.21433 16320330
24. D Mukerjee D St George B Coleiro C Knight CP Denton J Davar CM Black JG Coghlan 2003 Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach Ann Rheum Dis 62 1088 1093 10.1136/ard.62.11.1088 1:STN:280:DC%2BD3srgslKquw%3D%3D 14583573
25. M Ciurzyński P Bienias B Lichodziejewska K Kurnicka A Szewczyk M Glińska-Wielochowska M Kurzyna M Błaszczyk D Liszewska-Pfejfer P Pruszczyk 2008 Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis Clin Rheumatol 27 991 997 10.1007/s10067-008-0837-9 18256871
26. D Mukerjee LB Yap AM Holmes D Nair P Ayrton CM Black JG Coghlan 2003 Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension Respir Med 97 1230 1236 10.1016/S0954-6111(03)00254-3 1:STN:280:DC%2BD3srlsF2itA%3D%3D 14635979
27. T Dimitroulas G Giannakoulas H Karvounis M Gatzoulis L Settas 2010 Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension Semin Arthritis Rheum 39 478 484 10.1016/j.semarthrit.2009.03.005
28. Y Allanore D Borderie J Avouac D Zerkak C Meune E Hachulla L Mouthon L Guillevin O Meyer OG Ekindjian S Weber A Kahan 2008 High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis Arthritis Rheum 58 284 291 10.1002/art.23187 1:CAS:528:DC%2BD1cXhslOjtbg%3D 18163505
29. F Triposkiadis C Harbas G Kelepeshis G Sitafidis J Skoularigis V Demopoulos N Tsilimingas 2007 Left atrial remodeling in patients younger than 70 years with diastolic and systolic heart failure J Am Soc Echocardiogr 20 177 185 10.1016/j.echo.2006.08.013 17275704
30. S Maione G Cuomo A Giunta L Tanturri de Horatio G La Montagna F Manguso I Alagia G Valentini 2005 Echocardiographic alterations in systemic sclerosis: a longitudinal study Semin Arthritis Rheum 34 721 727 10.1016/j.semarthrit.2004. 11.001 15846587
31. C Meune J Avouac K Wahbi L Cabanes J Wipff L Mouthon L Guillevin A Kahan Y Allanore 2008 Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care: a controlled study of 100 consecutive patients Arthritis Rheum 58 1803 1809 10.1002/art.23463 18512815
32. MR Fisher SC Mathai HC Champion RE Girgis T Housten-Harris L Hummers JA Krishnan F Wigley PM Hassoun 2006 Clinical differences between idiopathic and scleroderma-related pulmonary hypertension Arthritis Rheum 54 3043 3050 10.1002/art.22069 16947776
33. G Tumminello P Lancellotti M Lempereur V D'Orio LA Pierard 2007 Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure Eur Heart J 28 569 574 10.1093/eurheartj/ehl561 17314112
34. TS Tsang ME Barnes BJ Gersh KR Bailey JB Seward 2002 Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden Am J Cardiol 90 1284 1289 10.1016/S0002-9149(02)02864-3 12480035
35. G Karayannis G Kitsios H Kotidis F Triposkiadis 2008 Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure Heart Fail Rev 13 91 98 10.1007/s10741-007-9021-6 17450425
36. TC Yeo KS Dujardin C Tei DW Mahoney MD McGoon JB Seward 1998 Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension Am J Cardiol 81 1157 1161 10.1016/S0002-9149(98)00140-4 1:STN:280:DyaK1c3ms1Sqtw%3D%3D 9605059
37. A Giunta E Tirri S Maione S Cangianiello A Mele A De Luca G Valentini 2000 Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension Ann Rheum Dis 59 94 98 10.1136/ard.59.2.94 1:STN:280:DC%2BD3c7ivFChtw%3D%3D 10666162
38. MC Vonk MH Sander FH van den Hoogen PL van Riel FW Verheugt AP van Dijk 2007 Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases Eur J Echocardiogr 8 317 321 10.1016/j.euje.2006.06.002 1:STN:280: DC%2BD2snitFCltA%3D%3D 16846757
39. WH Wilson Tang W Tong K Shrestha Z Wang BS Levison B Delfraino B Hu RW Troughton AL Klein SL Hazen 2008 Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure Eur Heart J 29 2506 2513 10.1093/eurheartj/ehn360 18687662
40. VD Steen TA Medsger 2007 Changes in causes of death in systemic sclerosis, 1972-2002 Ann Rheum Dis 66 940 944 10.1136/ard.2006.066068 17329309
41. MV Tsapenko AV Tsapenko TB Comfere GK Mour SV Mankad O Gajic 2008 Arterial pulmonary hypertension in noncardiac intensive care unit Vasc Health Risk Manag 4 1043 1060 1:CAS:528:DC%2BD1cXhsFWgs7rI 19183752
42. MM Hoeper SH Lee R Voswinckel M Palazzini X Jais A Marinelli RJ Barst HA Ghofrani ZC Jing C Opitz HJ Seyfarth M Halank V McLaughlin RJ Oudiz R Ewert H Wilkens S Kluge HC Bremer E Baroke LJ Rubin 2006 Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers J Am Coll Cardiol 48 2546 2552 10.1016/j.jacc.2006.07.061 17174196
43. G Keysser C Schwerdt C Taege 2008 Right-heart failure after right heart catheterization in a patient with scleroderma and suspected pulmonary hypertension Rheumatol Int 28 1269 1271 10.1007/s00296-008-0601-0 18500465